Abstract
Autoimmune diseases (ADs) and myelodysplastic syndrome (MDS) may be associated in approxi-mately 10–20% of cases. Although this association has been well recognized, it is not always easily diagnosed. The exact physiopathological mechanism involved has yet to be determined but seems to be multifactorial. The therapeutic decision is not well codified and often represents a challenge. But overall, glucocorticosteroids have generally proven to be effective at the expense of a high incidence of dependence and relapse. This review aims to summarize and analyze all aspects of this association to provide an overview for practitioners and clinicians.
A scientific search in databases (PubMed, Scopus, Web of Science, Google Scholar) was conducted using a combination of key words such as autoimmune diseases, myelodysplastic syndromes, and association. Articles from 1992 to 2022 were considered and relevant data were collected and sum-marized to provide a coherent detailed overview of the coexistence of ADs and MDS.
Reference48 articles.
1. Targeted Immunotherapy for Autoimmune Disease
2. Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases
3. Autoimmune Disease Classification Based on PubMed Text Mining
4. Khaniukov OO, Pesotskaya LA, Kravchenko OI, Shchukina OS. Current concepts of myelodysplastic syndrome: literature review. World Science: Problems, Prospects And Innovations. Proceedings of the 12th International scientific and practical conference. Perfect Pub-lishing, Toronto, Canada 2021; 44–51.
5. The Association between the Myelodysplastic Syndromes and Crohn Disease
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献